| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 37106 |
| 1 | METHOTREXATE SODIUM | 28460 |
| 2 | METHOTREXATE | 25816 |
| 3 | ADALIMUMAB | 23493 |
| 4 | LEFLUNOMIDE | 15719 |
| 5 | PREDNISONE | 14224 |
| 6 | ABATACEPT | 14003 |
| 7 | TOCILIZUMAB | 13280 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 12913 |
| 9 | SULFASALAZINE | 10981 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 170 | 0.8629 |
| 1 | GOLD | 1723 | 0.5026 |
| 2 | CORTISONE ACETATE | 1579 | 0.3792 |
| 3 | DESOXIMETASONE | 2093 | 0.3567 |
| 4 | PSEUDOEPHEDRINE HCL | 1122 | 0.3444 |
| 5 | CETIRIZINE HCL, PSEUDOEPHEDRINE HCL | 111 | 0.3136 |
| 6 | SODIUM BORATE | 14 | 0.2979 |
| 7 | SULFASALAZINE | 10981 | 0.2216 |
| 8 | HYPROMELLOSE 2910 | 18 | 0.2195 |
| 9 | LEFLUNOMIDE | 15719 | 0.2194 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 41343 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 25609 |
| 2 | Corticosteroid [EPC] | 17676 |
| 3 | Antirheumatic Agent [EPC] | 15728 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14183 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 14003 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 13805 |
| 7 | Aminosalicylate [EPC] | 11061 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 10231 |
| 9 | Vitamin C [EPC] | 9253 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 15728 | 0.2178 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 13805 | 0.2000 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 14003 | 0.1686 |
| 3 | Aminosalicylate [EPC] | 11061 | 0.1397 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1092 | 0.1162 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 25609 | 0.0878 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 10231 | 0.0735 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 41343 | 0.0552 |
| 8 | Vitamin D [EPC] | 9212 | 0.0525 |
| 9 | Prostaglandin E1 Analog [EPC] | 717 | 0.0514 |